Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Ferro

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
Cardiovascular Research|September 28, 2015
The role of inflammatory biomarkers in developing targeted cardiovascular therapies: lessons from the cardiovascular inflammation reduction trialsGabriella Passacquale, Paolo Di Giosia, Albert Ferro
Plos One|July 3, 2014
The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for myocardial infarction: a meta-analysisChristopher N Floyd, Agnesa Mustafa, Albert Ferro
British Journal of Clinical Pharmacology|January 10, 2022
Antiplatelet therapy in cardiovascular disease: Current status and future directionsGabriella Passacquale, Pankaj Sharma, Divaka Perera, et al.
British Journal of Clinical Pharmacology|December 10, 2016
Are nutraceuticals the modern panacea? From myth to sciencePietro Minuz, Giampaolo Velo, Francesco Violi, et al.
Oncotarget|November 22, 2017
The effect of aspirin on circulating netrin-1 levels in humans is dependent on the inflammatory status of the vascular endotheliumKerry Layne, Timothy Goodman, Albert Ferro, et al.
Journal of Hypertension|October 20, 2009
Nitric oxide dysfunction in vascular endothelium and platelets: role in essential hypertensionEugenia Gkaliagkousi, Stella Douma, Chrysanthos Zamboulis, et al.
JRSM Cardiovascular Disease|February 10, 2016
Expression of the PlA2 allele of glycoprotein IIIa and its impact on platelet functionChristopher N Floyd, Albert Ferro, Timothy D Warner
British Journal of Clinical Pharmacology|March 19, 2015
Antiplatelet therapy as a modulator of stroke aetiology: a meta-analysisChristopher A Rajkumar, Christopher N Floyd, Albert Ferro
Plos One|July 3, 2014
The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for stroke: a systematic review and meta-analysisChristopher N Floyd, Benjamin H Ellis, Albert Ferro
Cardiovascular Research|April 28, 2016
Anti-platelet drugs attenuate the expansion of circulating CD14highCD16+ monocytes under pro-inflammatory conditionsKerry Layne, Paolo Di Giosia, Albert Ferro, et al.
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
Cardiovascular Research|September 28, 2015
The role of inflammatory biomarkers in developing targeted cardiovascular therapies: lessons from the cardiovascular inflammation reduction trialsGabriella Passacquale, Paolo Di Giosia, Albert Ferro
Plos One|July 3, 2014
The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for myocardial infarction: a meta-analysisChristopher N Floyd, Agnesa Mustafa, Albert Ferro
British Journal of Clinical Pharmacology|January 10, 2022
Antiplatelet therapy in cardiovascular disease: Current status and future directionsGabriella Passacquale, Pankaj Sharma, Divaka Perera, et al.
British Journal of Clinical Pharmacology|December 10, 2016
Are nutraceuticals the modern panacea? From myth to sciencePietro Minuz, Giampaolo Velo, Francesco Violi, et al.
Oncotarget|November 22, 2017
The effect of aspirin on circulating netrin-1 levels in humans is dependent on the inflammatory status of the vascular endotheliumKerry Layne, Timothy Goodman, Albert Ferro, et al.
Journal of Hypertension|October 20, 2009
Nitric oxide dysfunction in vascular endothelium and platelets: role in essential hypertensionEugenia Gkaliagkousi, Stella Douma, Chrysanthos Zamboulis, et al.
JRSM Cardiovascular Disease|February 10, 2016
Expression of the PlA2 allele of glycoprotein IIIa and its impact on platelet functionChristopher N Floyd, Albert Ferro, Timothy D Warner
British Journal of Clinical Pharmacology|March 19, 2015
Antiplatelet therapy as a modulator of stroke aetiology: a meta-analysisChristopher A Rajkumar, Christopher N Floyd, Albert Ferro
Plos One|July 3, 2014
The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for stroke: a systematic review and meta-analysisChristopher N Floyd, Benjamin H Ellis, Albert Ferro
Cardiovascular Research|April 28, 2016
Anti-platelet drugs attenuate the expansion of circulating CD14highCD16+ monocytes under pro-inflammatory conditionsKerry Layne, Paolo Di Giosia, Albert Ferro, et al.
Pageof 13